Home > Insider Trading > Filing (0000921895-23-000615)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1829802	Sensei Biotherapeutics Inc.	SNSE	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1828422	Presight Sensei Co-Invest Fund, L.p.	340 S. Lemon Ave., # 3391 Walnut CA 91789	No	No	No	Yes
1845711	Ltd. Group Investment Apeiron	Beatrice, At 66 &Amp; 67 Amery Street Sliema O1 SLM1707	No	No	Yes	No
1845872	Christian Angermayer	Beatrice, At 66 &Amp; 67 Amery Street Sliema O1 SLM1707	No	No	Yes	No
1846009	Presight Co-Invest Management, L.l.c.	340 S. Lemon Ave. #3391 Walnut CA 91789	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-02-23	1,100	$1.62	2,484,823	No	4	P	Indirect	By Apeiron Investment Group Ltd.
Common Stock	Acquisiton	2023-02-23	1,100	$1.60	2,485,923	No	4	P	Indirect	By Apeiron Investment Group Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Apeiron Investment Group Ltd.
No	4	P	Indirect	By Apeiron Investment Group Ltd.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	955,738	Indirect	By Presight Sensei Co-Invest Fund, L.P.

Footnotes

This Form 4 is filed jointly by Apeiron Investment Group Ltd. ("Apeiron"), Christian Angermayer, Presight Sensei Co-Invest Fund, L.P. ("Presight Co-Invest") and Presight Sensei Co-Invest Management, L.L.C. ("Presight Co-Invest Management", and collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Securities owned directly by Apeiron. Mr. Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities owned directly by Apeiron.
Securities owned directly by Presight Co-Invest. As the general partner of Presight Co-Invest, Presight Co-Invest Management may be deemed to beneficially own the securities owned directly by Presight Co-Invest. As the sole member of Presight Co-Invest Management, Apeiron may be deemed to beneficially own the securities owned directly by Presight Co-Invest. Mr. Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities owned directly by Presight Co-Invest.